The impact of continuous glucose monitoring on glycaemic control, pregnancy outcomes, and participant-reported outcomes in women with gestational diabetes: a systematic review and individual participant meta-analysis
To create a formal platform for collaboration between RCTs and cohorts that facilitates high-quality studies on the efficacy of continuous glucose monitoring (CGM) for women with gestational diabetes (GDM) on glycaemic control in pregnancy, maternal and neonatal pregnancy outcomes, participant-reported outcomes, the association between CGM metrics and pregnancy outcomes, and the risk for hyperglycaemia postpartum.
To create a collaboration infrastructure that allows for individual participant-based meta-analyses and studies in populations large enough to answer clinically relevant questions in the field.
The consortium is open access, and those interested in collaborating, sponsoring or performing studies are more than welcome to contact us.
Members to be announced.
Members to be announced.
This website is dedicated to the Elysa Consortium on CGM in Gestational Diabetes.International Consortium about the Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes DOI: 10.1016/S2213-8587(25)00335-3
Epidemiology and management of gestational diabetes DOI: 10.1016/S0140-6736(24)00825-0